MK-0991

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-0991, covering 2013-05-10 to 2016-10-13. Get the full timeline:

Most recent: Clinical Trial Update: A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)